Literature DB >> 19759334

Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells.

Shelby C Young1, Megan V Storm, Joshua S Speed, Silvia Kelsen, Chelsea V Tiller, Trinity Vera, Heather A Drummond, David E Stec.   

Abstract

Induction of heme oxygenase-1 (HO-1) in the renal medulla increases carbon monoxide and bilirubin production and decreases ANG II-mediated superoxide production. The goal of this study was to determine the importance of increases in bilirubin to the antioxidant effects of HO-1 induction in cultured mouse thick ascending loop of Henle (TALH) and inner medullary collecting duct (IMCD3) cells. Bilirubin levels were decreased by using small interfering RNAs (siRNAs) targeted to biliverdin reductase (BVR), which is the cellular enzyme responsible for the conversion of biliverdin to bilirubin. Treatment of cultured TALH or IMCD-3 cells with BVR siRNA (50 or 100 nM) resulted in an 80% decrease in the level of BVR protein and decreased cellular bilirubin levels from 46 +/- 5 to 23 +/- 4 nM (n = 4). We then determined the effects of inhibition of BVR on ANG II-mediated superoxide production. Superoxide production induced by ANG II (10(-9) M) significantly increased in both TALH and IMCD-3 cells. Treatment of TALH cells with BVR siRNA resulted in a significant increase in ouabain-sensitive rubidium uptake from 95 +/- 6 to 122 +/- 5% control (n = 4, P < 0.05). Lastly, inhibition of BVR with siRNA did not prevent the decrease in superoxide levels observed in cells pretreated with the HO-1 inducer, hemin. We conclude that decreased levels of cellular bilirubin increase ANG II-mediated superoxide production and sodium transport; however, increases in bilirubin are not necessary for HO-1 induction to attenuate ANG II-mediated superoxide production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759334      PMCID: PMC2777783          DOI: 10.1152/ajpregu.90933.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  28 in total

1.  Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.

Authors:  Hanke Mollnau; Maria Wendt; Katalin Szöcs; Bernard Lassègue; Eberhard Schulz; Mathias Oelze; Huige Li; Martin Bodenschatz; Michael August; Andrei L Kleschyov; Nikolaus Tsilimingas; Ulrich Walter; Ulrich Förstermann; Thomas Meinertz; Kathy Griendling; Thomas Münzel
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

2.  Interaction of O(2)(-) and NO in the thick ascending limb.

Authors:  Pablo A Ortiz; Jeffrey L Garvin
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

3.  Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells.

Authors:  W Tian; H L Bonkovsky; S Shibahara; D M Cohen
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

4.  Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells.

Authors:  Z Z Yang; A P Zou
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

5.  Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.

Authors:  Zulfiqar Ahmad; Mohammad Salim; Mahin D Maines
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

6.  Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension.

Authors:  Trinity Vera; Silvia Kelsen; David E Stec
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

7.  Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells.

Authors:  Silvia Kelsen; Bijal J Patel; Lawson B Parker; Trinity Vera; John M Rimoldi; Rama S V Gadepalli; Heather A Drummond; David E Stec
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13

8.  Isoforms and functions of NAD(P)H oxidase at the macula densa.

Authors:  Rui Zhang; Pamela Harding; Jeffrey L Garvin; Ramiro Juncos; Ed Peterson; Luis A Juncos; Ruisheng Liu
Journal:  Hypertension       Date:  2009-02-09       Impact factor: 10.190

9.  In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin.

Authors:  Andrew C Bulmer; Joanne T Blanchfield; Jeff S Coombes; Istvan Toth
Journal:  Bioorg Med Chem       Date:  2008-02-08       Impact factor: 3.641

Review 10.  Pharmacological and clinical aspects of heme oxygenase.

Authors:  Nader G Abraham; Attallah Kappas
Journal:  Pharmacol Rev       Date:  2008-03-06       Impact factor: 25.468

View more
  11 in total

Review 1.  Heme oxygenase, a novel target for the treatment of hypertension and obesity?

Authors:  Peter A Hosick; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

Review 2.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

3.  Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension.

Authors:  David E Stec; Luis A Juncos; Joey P Granger
Journal:  J Am Soc Hypertens       Date:  2016-01-30

Review 4.  Effects of reactive oxygen species on renal tubular transport.

Authors:  Agustin Gonzalez-Vicente; Nancy Hong; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-19

5.  Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

6.  Antihypertensive actions of moderate hyperbilirubinemia: role of superoxide inhibition.

Authors:  David E Stec; Megan V Storm; Brandon E Pruett; Monette U Gousset
Journal:  Am J Hypertens       Date:  2013-03-12       Impact factor: 2.689

7.  Rv2074 is a novel F420 H2 -dependent biliverdin reductase in Mycobacterium tuberculosis.

Authors:  F Hafna Ahmed; A Elaaf Mohamed; Paul D Carr; Brendon M Lee; Karmen Condic-Jurkic; Megan L O'Mara; Colin J Jackson
Journal:  Protein Sci       Date:  2016-07-17       Impact factor: 6.725

8.  Bilirubin, renal hemodynamics, and blood pressure.

Authors:  David E Stec; Peter A Hosick; Joey P Granger
Journal:  Front Pharmacol       Date:  2012-02-14       Impact factor: 5.810

9.  Renal Inhibition of Heme Oxygenase-1 Increases Blood Pressure in Angiotensin II-Dependent Hypertension.

Authors:  Eva Csongradi; Megan V Storm; David E Stec
Journal:  Int J Hypertens       Date:  2011-11-16       Impact factor: 2.420

10.  Direct Antioxidant Properties of Bilirubin and Biliverdin. Is there a Role for Biliverdin Reductase?

Authors:  Thomas Jansen; Andreas Daiber
Journal:  Front Pharmacol       Date:  2012-03-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.